Key facts
- It has raised $11.0M; the latest was Later Stage VC in Dec 2025.
- Notable investors include Enterprise Ireland, MedTech Innovator, Boole Investment Syndicate, EIT Health, Furthr — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for SymPhysis Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for SymPhysis Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SymPhysis Medical
Developer of a therapeutic device designed to manage malignant pleural effusions in the home setting. The company's device drains excess fluid from the pleural space using an active component that enhances removal efficiency to alleviate symptoms such as difficulty breathing and chest pain, enabling patients to improve their quality of life and making indwelling pleural catheter (IPC) treatments more accessible.
- Sector
- Healthcare
- HQ
- Galway, Ireland
- Founded
- 2018
- Employees
- 18
- Website
- symphysismedical.com/
- Ownership
- Privately Held (backing)
SymPhysis Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SymPhysis Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SymPhysis Medical in its N-PORT filings yet. We sweep new filings monthly.